The effect of daily oral administration of 50-100 mg aspirin was evaluated in 8 patients (Table 1) . Platelet aggregation and platelet malondialdehyde (MDA) production were significantly inhibited after administration of aspirin for a week. Plasma thromboxane-B2 (TXB2) levels showed a tendency to decrease (0. 1<p <0.05).
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Plasma j3-thromboglobulin (j3-TG) and platelet factor 4 (PF4) were not decreased. In order to detect intracardiac thrombi and evaluate the effect of aspirin therapy, platelet survival and accumulation of radioactivity in the thrombus using In-111-labeled autologous platelets were observed in two patients wite heart diseases before and after the aspirin therapy. A case of mitral stenosis with left atrial thrombi showed that the radioactivity on the thrombus was slightly decreased and platelet survival prolonged from 6. 1 to 6. 6 days during the administration of 50 mg aspirin. In this case, plasma thromboxane B2 level was decreased from 130 to 50 pg/ml and platelet aggregation was markedly inhibited during the therapy.
Another case of myocardial infarction with left ventricular thrombi showed that the radioactivity on the thrombus was slightly decreased and platelet survival prolonged from 7. 6 to 8. 2 days during the administration of 50 mg aspirin. In this case, platelet aggregation induced by ADP and epinephrine were markedly inhibited, but plasma thromboxane B2 level was not changed. Daily low-dose of aspirin inhibited platelet aggregation and platelet MDA production, but did not inhibit plasma TXB2, j3-TG and PF4. Platelet survival after aspirin administration slightly prolonged and accumulation of labeled platelets on the thrombi supressed in slight degree in comparison with these before aspirin administration. Med., 308; 800-805, 1983 .
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